Prometic is a global biopharmaceutical company offering technologies for large-scale drug purification, drug development, proteomics (the study of proteins), and the elimination of pathogens. Prometic is also active in therapeutic drug development with the mission of bringing to market effective, innovative, lower cost products for the treatment of hematological and nephrological disorders and cancer. Headquartered in MontrŽal (Canada), Prometic has R&D facilities in the UK, the USA and Canada, manufacturing facilities in the UK and business development activities in the USA, Europe, Asia and in the Middle-East. Prometic focuses its activities in the Protein Technologies and Therapeutics markets.